Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 52

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4–18 years

Groen, Jip, Gordon, Morris, Chogle, Ashish, Benninga, Marc, Borlack, Rachel, Borrelli, Osvaldo, Darbari, Anil, Dolinsek, Jernej, Khlevner, Julie, Di Lorenzo, Carlo, Person, Hannibal, Sanghavi, Rinarani, Snyder, Julie, Thapar, Nikhil, Vlieger, Arine, Sinopoulou, Vasiliki, Tabbers, Merit, Saps, Miguel·2025·Journal of Pediatric Gastroenterology and Nutrition
DOI 10.1002/jpn3.70070
Open this paper in CoChat — free account

Abstract

Objectives: Abdominal pain related disorders of gut–brain interaction (AP‐DGBIs) such as irritable bowel syndrome (IBS) and functional abdominal pain‐not otherwise specified (FAP) are common conditions in children, significantly impacting quality of life. This treatment guideline for IBS and FAP in children of 4–18 years is a collaborative effort of the European and North American Societies for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN and NASPGHAN). We aim to comprehensively review the current evidence on treatment options and offer evidence‐based recommendations with utility across all treatment settings worldwide, as well as to provide methodological directions for future research. Methods: The guideline development followed the “Grading of Recommendations Assessment, Development and Evaluation” (GRADE) approach, which is in accordance with the GRADE handbook and supported by the World Health Organization. The Guideline Development Group (GDG) comprised clinical experts, representing ESPGHAN, NASPGHAN, and Cochrane. Individual members have put forward a final consensus list of treatment options, which were then translated into “patient, intervention, comparison, outcome” (PICO) format options. Prospective agreement on decision thresholds for efficacy and safety outcomes was reached through a Delphi process among the GDG to support GRADEing of the literature. Consensus voting was used to finalize recommendations, and a treatment algorithm was developed. Results: Systematic literature searches for this output identified 86 original randomized controlled trials assessing treatment of IBS and FAP. Consensus was reached for 25 GRADEd recommendations. Ten best practice statements were formulated, and guidance for future research methodology was proposed. Conclusion: This guideline represents the first collaborative output of ESPGHAN and NASPGHAN on treatment options for AP‐DGBIs. Systematic review of the evidence has exposed major evidence gaps for the treatment of these disorders and incentivizes large pediatric trials, particularly on treatment options for which, to date, no evidence exists.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jpn3.70070

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 122

  1. Youssef NN, 2008, Chronic abdominal pain and depressive symptoms: analysis of the national longitudinal study of adolescent health, Clin Gastroenterol Hepatol, 6, 329, 10.1016/j.cgh.2007.12.019 · DOI
  2. Hoekman DR, 2015, Annual costs of care for pediatric irritable bowel syndrome, functional abdominal pain, and functional abdominal pain syndrome, J Pediatr, 167, 1103, 10.1016/j.jpeds.2015.07.058 · DOI
  3. Lewis ML, 2016, Prevalence of functional gastrointestinal disorders in children and adolescents, J Pediatr, 177, 39, 10.1016/j.jpeds.2016.04.008 · DOI · Paper page
  4. Dhroove G, 2010, A million‐dollar work‐up for abdominal pain: is it worth it?, J Pediatr Gastroenterol Nutr, 51, 579, 10.1097/MPG.0b013e3181de0639 · DOI
  5. Hyams JS, 2016, Functional disorders: children and adolescents, Gastroenterology, 150, 1456, 10.1053/j.gastro.2016.02.015 · DOI · Paper page
  6. Rutten JMTM, 2014, IBS and FAPS in children: a comparison of psychological and clinical characteristics, J Pediatr Gastroenterol Nutr, 59, 493, 10.1097/MPG.0000000000000452 · DOI
  7. Bruijn CM, 2022, Dietary interventions for functional abdominal pain disorders in children: a systematic review and meta‐analysis, Expert Rev Gastroenterol Hepatol, 16, 359, 10.1080/17474124.2022.2055547 · DOI
  8. Gordon M, 2022, Psychosocial interventions for the treatment of functional abdominal pain disorders in children: a systematic review and meta‐analysis, JAMA Pediatr, 176, 560, 10.1001/jamapediatrics.2022.0313 · DOI
  9. Rexwinkel R, 2021, Pharmacologic treatment in functional abdominal pain disorders in children: a systematic review, Pediatrics, 147, 10.1542/peds.2020-042101 · DOI
  10. Wallace C, 2023, Probiotics for management of functional abdominal pain disorders in children, Cochrane Database Syst Rev, 2
  11. Tabbers MM, 2014, Evaluation and treatment of functional constipation in infants and children: evidence‐based recommendations from ESPGHAN and NASPGHAN, J Pediatr Gastroenterol Nutr, 58, 258, 10.1097/MPG.0000000000000266 · DOI
  12. Schünemann HBJ, 2013, GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations
  13. Gordon M, 2023, ESPGHAN and NASPGHAN 2023 protocol for paediatric FAPD treatment guidelines (standard operating procedure), BMJ Paediatr Open, 7, 10.1136/bmjpo-2023-002166 · DOI
  14. Gordon M, 2023, BSG 2024 IBD guidelines protocol (standard operating procedures), BMJ Open Gastroenterol, 10, 10.1136/bmjgast-2022-001067 · DOI
  15. Zeevenhooven J, 2020, A core outcome set for clinical trials in pediatric functional abdominal pain disorders, J Pediatr, 221, 115, 10.1016/j.jpeds.2020.02.032 · DOI · Paper page
  16. Nasa P, 2021, Delphi methodology in healthcare research: how to decide its appropriateness, World J Methodol, 11, 116, 10.5662/wjm.v11.i4.116 · DOI · Paper page
  17. Morgano GP, 2022, Defining decision thresholds for judgments on health benefits and harms using the grading of recommendations assessment, development and evaluation (GRADE) evidence to decision (EtD) frameworks: a protocol for a randomised methodological study (GRADE‐THRESHOLD), BMJ Open, 12, 10.1136/bmjopen-2021-053246 · DOI
  18. Shaban N, 2024, DOP02 developing explicit thresholds for outcomes to inform (GRADE) evidence to decision frameworks for inflammatory bowel disease guidelines, J Crohn's Colitis, 18, i73, 10.1093/ecco-jcc/jjad212.0042 · DOI
  19. Sinopoulou V, 2024, Prepublication abstract‐only reports compared with full‐text manuscripts for randomised controlled trials in inflammatory bowel disease: a systematic review, BMJ Open Gastroenterol, 11, 10.1136/bmjgast-2023-001334 · DOI
  20. Gordon MKJ, 2024, Quality of reporting of inflammatory bowel disease trials: a systematic review, BMJ Open Gastro, 10.1136/bmjgast-2023-001337 · DOI
  21. Alonso‐Coello P, 2016, GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction, BMJ, 353, i2016, 10.1136/bmj.i2016 · DOI · Paper page
  22. Vlieger AM, 2007, Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial, Gastroenterology, 133, 1430, 10.1053/j.gastro.2007.08.072 · DOI
  23. Gulewitsch MD, 2013, Brief hypnotherapeutic‐behavioral intervention for functional abdominal pain and irritable bowel syndrome in childhood: a randomized controlled trial, Eur J Pediatr, 172, 1043, 10.1007/s00431-013-1990-y · DOI
  24. Gulewitsch MD, 2017, Comparison of gut‐directed hypnotherapy and unspecific hypnotherapy as self‐help format in children and adolescents with functional abdominal pain or irritable bowel syndrome: a randomized pilot study, Eur J Gastroenterol Hepatol, 29, 1351, 10.1097/MEG.0000000000000984 · DOI
  25. Rutten JMTM, 2017, Home‐based hypnotherapy self‐exercises vs individual hypnotherapy with a therapist for treatment of pediatric irritable bowel syndrome, functional abdominal pain, or functional abdominal pain syndrome: a randomized clinical trial, JAMA Pediatr, 171, 470, 10.1001/jamapediatrics.2017.0091 · DOI
  26. Pas R, 2020, Pain neuroscience education for children with functional abdominal pain disorders: a randomized comparative pilot study, J Clin Med, 9, 1797, 10.3390/jcm9061797 · DOI
  27. Weydert JA, 2006, Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial, BMC Pediatr, 6, 29, 10.1186/1471-2431-6-29 · DOI
  28. Youssef NN, 2009, 1007 feasibility and efficacy of pilot study investigating a school nurse administered guided imagery program for childhood functional abdominal pain, Gastroenterology, 136, 10.1016/S0016-5085(09)60705-8 · DOI
  29. Tilburg MAL, 2009, Audio‐recorded guided imagery treatment reduces functional abdominal pain in children: a pilot study, Pediatrics, 124, e890, 10.1542/peds.2009-0028 · DOI
  30. Alfvén G, 2007, A new method for the treatment of recurrent abdominal pain of prolonged negative stress origin, Acta Paediatr (Stockholm), 96, 76, 10.1111/j.1651-2227.2006.00028.x · DOI
  31. Bonnert M, 2019, Internet‐delivered exposure‐based cognitive‐behavioral therapy for adolescents with functional abdominal pain or functional dyspepsia: a feasibility study, Behav Ther, 50, 177, 10.1016/j.beth.2018.05.002 · DOI
  32. Cunningham NR, 2021, Cognitive behavior therapy tailored to anxiety symptoms improves pediatric functional abdominal pain outcomes: a randomized clinical trial, J Pediatr, 230, 62, 10.1016/j.jpeds.2020.10.060 · DOI
  33. Duarte MA, 2006, Treatment of nonorganic recurrent abdominal pain: cognitive‐behavioral family intervention, J Pediatr Gastroenterol Nutr, 43, 59, 10.1097/01.mpg.0000226373.10871.76 · DOI
  34. Groß M, 2013, Evaluation of a cognitive‐behavioral pain management program for children with chronic abdominal pain: a randomized controlled study, Int J Behav Med, 20, 434, 10.1007/s12529-012-9228-3 · DOI
  35. Humphreys PA, 2000, Treatment of recurrent abdominal pain: components analysis of four treatment protocols, J Pediatr Gastroenterol Nutr, 31, 47
  36. Nieto R, 2019, Effects and experiences of families following a web‐based psychosocial intervention for children with functional abdominal pain and their parents: a mixed‐methods pilot randomized controlled trial, J Pain Res, 12, 3395, 10.2147/JPR.S221227 · DOI
  37. Sanders MR, 1989, Cognitive‐behavioral treatment of recurrent nonspecific abdominal pain in children: an analysis of generalization, maintenance, and side effects, J Consult Clin Psychol, 57, 294, 10.1037/0022-006X.57.2.294 · DOI
  38. Sanders MR, 1994, The treatment of recurrent abdominal pain in children: a controlled comparison of cognitive‐behavioral family intervention and standard pediatric care, J Consult Clin Psychol, 62, 306, 10.1037/0022-006X.62.2.306 · DOI · Paper page
  39. Veek SMC, 2013, Cognitive behavior therapy for pediatric functional abdominal pain: a randomized controlled trial, Pediatrics, 132, e1163, 10.1542/peds.2013-0242 · DOI
  40. Walker LS, 2021, Internet‐delivered cognitive behavioral therapy for youth with functional abdominal pain: a randomized clinical trial testing differential efficacy by patient subgroup, Pain, 162, 2945, 10.1097/j.pain.0000000000002288 · DOI
  41. Wallander JL, 2011, A randomised controlled trial of written self‐disclosure for functional recurrent abdominal pain in youth, Psychol Health, 26, 433, 10.1080/08870440903477212 · DOI
  42. Warschburger P, 2021, Do children with functional abdominal pain benefit more from a pain‐specific cognitive‐behavioral intervention than from an unspecific attention control intervention? Results of a randomized controlled trial, Am J Gastroenterol, 116, 1322, 10.14309/ajg.0000000000001191 · DOI
  43. Wassom MC, 2013, A pilot study of “Gutstrong” for adolescents with functional gastrointestinal disorders, Clin Pract Pediatr Psychol, 1, 201
  44. Levy RL, 2017, Brief telephone‐delivered cognitive behavioral therapy targeted to parents of children with functional abdominal pain: a randomized controlled trial, Pain, 158, 618, 10.1097/j.pain.0000000000000800 · DOI
  45. Sator‐Katzenschlager SM, 2007, P‐Stim™ auricular electroacupuncture stimulation device for pain relief, Expert Rev Med Devices, 4, 23, 10.1586/17434440.4.1.23 · DOI
  46. Ahmed HE, 1998, Percutaneous electrical nerve stimulation (PENS): a complementary therapy for the management of pain secondary to bony metastasis, Clin J Pain, 14, 320, 10.1097/00002508-199812000-00009 · DOI
  47. Liu X, 2015, Effect of environmental sulfur on the structure of alumina scales formed on Ni‐base alloys, Acta Mater, 97, 41, 10.1016/j.actamat.2015.06.031 · DOI
  48. Folan‐curran J, 1994, Innervation of the rat external auditory meatus: a retrograde tracing study, Somatosens Mot Res, 11, 65, 10.3109/08990229409028858 · DOI
  49. Contreras RJ, 1982, The central projections of the trigeminal, facial, glossopharyngeal and vagus nerves: an autoradiographic study in the rat, J Auton Nerv Syst, 6, 303, 10.1016/0165-1838(82)90003-0 · DOI
  50. Kovacic K, 2017, Neurostimulation for abdominal pain‐related functional gastrointestinal disorders in adolescents: a randomised, double‐blind, sham‐controlled trial, Lancet Gastroenterol Hepatol, 2, 727, 10.1016/S2468-1253(17)30253-4 · DOI
  51. Krasaelap A, 2020, Efficacy of auricular neurostimulation in adolescents with irritable bowel syndrome in a randomized, double‐blind trial, Clin Gastroenterol Hepatol, 18, 1987, 10.1016/j.cgh.2019.10.012 · DOI
  52. Kamphorst K, 2022, Neonatal antibiotics and food allergy are associated with FGIDs at 4‐6 years of age, J Pediatr Gastroenterol Nutr, 74, 770, 10.1097/MPG.0000000000003428 · DOI
  53. Uusijärvi A, 2014, Use of antibiotics in infancy and childhood and risk of recurrent abdominal pain—a Swedish birth cohort study, Neurogastroenterol Motil, 26, 841, 10.1111/nmo.12340 · DOI
  54. Baştürk A, 2016, Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: a randomized controlled trial, Turk J Gastroenterol, 27, 439, 10.5152/tjg.2016.16301 · DOI
  55. Eftekhari K, 2015, A randomized double‐blind placebo‐controlled trial of Lactobacillus reuteri for chronic functional abdominal pain in children, Iran J Ped, 25
  56. Giannetti E, 2017, A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double‐blind, placebo‐controlled, crossover trial, J Clin Gastroenterol, 51, e5, 10.1097/MCG.0000000000000528 · DOI · Paper page
  57. Jadrešin O, 2020, Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: results of the double‐blind randomized study, Clin Nutr, 39, 3645, 10.1016/j.clnu.2020.04.019 · DOI
  58. Jafari SS, 2022, Ability of polymicrobial probiotic and mono‐strain probiotic to reduce functional abdominal pain in children: a randomized clinical trial, Clin Exp Pediatr, 65, 589, 10.3345/cep.2022.00339 · DOI
  59. Rahmani P, 2020, Evaluating the effects of probiotics in pediatrics with recurrent abdominal pain, Clin Exp Pediatr, 63, 485, 10.3345/cep.2019.01613 · DOI
  60. Sabbi T, 2011, PP223‐MON the use of Lactobacillus GG in children with functional abdominal pain: a double‐blind randomized control trial, Clin Nutr Suppl, 6, 198, 10.1016/S1744-1161(11)70513-0 · DOI
  61. Vázquez‐Frias R, 2023, Efficacy and safety of the adjuvant use of probiotic Bacillus clausii strains in pediatric irritable bowel syndrome: a randomized, double‐blind, placebo‐controlled study, Pediatric Drugs, 25, 115, 10.1007/s40272-022-00536-9 · DOI
  62. Asgarshirazi M, 2015, Comparison of the effects of pH‐dependent peppermint oil and synbiotic lactol (Bacillus coagulans + fructooligosaccharides) on childhood functional abdominal pain: a randomized placebo‐controlled study, Iran Red Crescent Med J, 17, 10.5812/ircmj.17(4)2015.23844 · DOI
  63. Bausserman M, 2005, The use of Lactobacillus GG in irritable bowel syndrome in children: a double‐blind randomized control trial, J Pediatr, 147, 197, 10.1016/j.jpeds.2005.05.015 · DOI · Paper page
  64. Gholizadeh A, 2021, Effect of a synbiotic on functional abdominal pain in childhood, Caspian J Intern Med, 12, 194
  65. Kianifar H, 2015, Probiotic for irritable bowel syndrome in pediatric patients: a randomized controlled clinical trial, Electron Physician, 7, 1255
  66. Otuzbir A, 2016, Efficiency and immunologic effects of synbiotics in children with functional abdominal pain, J Pediatr Gastroenterol Nutr, 62, 426
  67. Saneian H, 2015, Synbiotic containing Bacillus coagulans and fructo‐oligosaccharides for functional abdominal pain in children, Gastroenterol Hepatol Bed Bench, 8, 56
  68. Sudha MR, 2018, Efficacy of Bacillus coagulans unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study, Benef Microbes, 9, 563, 10.3920/BM2017.0129 · DOI
  69. Kline RM, 2001, Enteric‐coated, pH‐dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children, J Pediatr, 138, 125, 10.1067/mpd.2001.109606 · DOI · Paper page
  70. Ingrosso MR, 2022, Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome, Aliment Pharmacol Ther, 56, 932, 10.1111/apt.17179 · DOI · Paper page
  71. Bannister K, 2016, What do monoamines do in pain modulation?, Curr Opin Support Palliat Care, 10, 143, 10.1097/SPC.0000000000000207 · DOI
  72. Mayer EA, 2015, Towards a systems view of IBS, Nat Rev Gastroenterol Hepatol, 12, 592, 10.1038/nrgastro.2015.121 · DOI · Paper page
  73. Bahar RJ, 2008, Double‐blind placebo‐controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents, J Pediatr, 152, 685, 10.1016/j.jpeds.2007.10.012 · DOI
  74. Saps M, 2009, Multicenter, randomized, placebo‐controlled trial of amitriptyline in children with functional gastrointestinal disorders, Gastroenterology, 137, 1261, 10.1053/j.gastro.2009.06.060 · DOI · Paper page
  75. Seetharaman J, 2022, Efficacy of amitriptyline in pediatric functional abdominal pain disorders: a randomized placebo‐controlled trial, J Gastroenterol Hepatol, 37, 685, 10.1111/jgh.15765 · DOI
  76. Puoti MG, 2023, Drugs in focus: domperidone, J Pediatr Gastroenterol Nutr, 77, e13, 10.1097/MPG.0000000000003822 · DOI
  77. Karunanayake A, 2019, Autonomic functions and gastric motility in children with functional abdominal pain disorders, World J Gastroenterol, 25, 95, 10.3748/wjg.v25.i1.95 · DOI
  78. Karunanayake A, 2018, Randomized controlled clinical trial on value of domperidone in functional abdominal pain in children, J Pediatr Gastroenterol Nutr, 66, 725, 10.1097/MPG.0000000000001819 · DOI
  79. Tavakoli Haghighiand N, 2023, Effect of domperidone on children with functional abdominal pain: a randomized controlled clinical trial, Shiraz E‐Med J, 24, 10.5812/semj-128504 · DOI
  80. Milo R, 1980, Use of the peripheral dopamine antagonist, domperidone, in the management of gastro‐intestinal symptoms in patients with irritable bowel syndrome, Curr Med Res Opin, 6, 577, 10.1185/03007998009109491 · DOI
  81. Junqueira DR, 2023, Risk of adverse events associated with domperidone and metoclopramide in gastroparesis: systematic review and meta‐analysis, Drugs R&D, 23, 1
  82. Rodriguez L, 2013, Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children, J Pediatr, 163, 261, 10.1016/j.jpeds.2012.12.096 · DOI
  83. Sadeghian M, 2008, Cyproheptadine for the treatment of functional abdominal pain in childhood: a double‐blinded randomized placebo‐controlled trial, Minerva Pediatr, 60, 1367
  84. Hojsak I, 2022, Benefits of dietary fibre for children in health and disease, Arch Dis Child, 107, 973, 10.1136/archdischild-2021-323571 · DOI
  85. Gill SK, 2021, Dietary fibre in gastrointestinal health and disease, Nat Rev Gastroenterol Hepatol, 18, 101, 10.1038/s41575-020-00375-4 · DOI · Paper page
  86. Feldman W, 1985, The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double‐blind, randomized, controlled trial, Am J Dis Child, 139, 1216, 10.1001/archpedi.1985.02140140050025 · DOI
  87. Horvath A, 2013, Glucomannan for abdominal pain‐related functional gastrointestinal disorders in children: a randomized trial, World J Gastroenterol, 19, 3062, 10.3748/wjg.v19.i20.3062 · DOI
  88. Menon J, 2023, Efficacy of oral psyllium in pediatric irritable bowel syndrome: a double‐blind randomized control trial, J Pediatr Gastroenterol Nutr, 76, 14, 10.1097/MPG.0000000000003622 · DOI
  89. Romano C, 2013, Partially hydrolyzed guar gum in pediatric functional abdominal pain, World J Gastroenterol, 19, 235, 10.3748/wjg.v19.i2.235 · DOI
  90. Tack J, 2009, A placebo‐controlled trial of the 5‐HT1A agonist R‐137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia, Neurogastroenterol Motil, 21, 619, 10.1111/j.1365-2982.2008.01260.x · DOI
  91. Parkman HP, 2023, Buspirone for early satiety and symptoms of gastroparesis: a multi‐centre, randomised, placebo‐controlled, double‐masked trial (BESST), Aliment Pharmacol Ther, 57, 1272, 10.1111/apt.17479 · DOI
  92. Badihian N, 2020, Comparison of the efficacy of buspirone and placebo in childhood functional abdominal pain: a randomized clinical trial, Am J Gastroenterol, 115, 756, 10.14309/ajg.0000000000000589 · DOI
  93. Den Hertog A, 1987, Modification of α1‐receptor‐operated channels by mebeverine in smooth muscle cells of guinea‐pig taenia caeci, Eur J Pharmacol, 138, 367, 10.1016/0014-2999(87)90475-4 · DOI
  94. Greenslade FC, 1982, Heterogeneity of biochemical actions among vasodilators, J Pharm Sci, 71, 94, 10.1002/jps.2600710123 · DOI
  95. Patai Z, 2016, Potential L‐type voltage‐operated calcium channel blocking effect of drotaverine on functional models, J Pharmacol Exp Ther, 359, 442, 10.1124/jpet.116.237271 · DOI
  96. Pourmoghaddas Z, 2014, Mebeverine for pediatric functional abdominal pain: a randomized, placebo‐controlled trial, BioMed Res Int, 2014, 10.1155/2014/191026 · DOI
  97. Narang M, 2015, Efficacy and safety of drotaverine hydrochloride in children with recurrent abdominal pain: a randomized placebo controlled trial, Indian Pediatr, 52, 847, 10.1007/s13312-015-0730-y · DOI
  98. Darvish‐Damavandi M, 2010, A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome, World J Gastroenterol, 16, 547, 10.3748/wjg.v16.i5.547 · DOI
  99. Grondin JA, 2023, Emerging roles of gut serotonin in regulation of immune response, microbiota composition and intestinal inflammation, J Can Assoc Gastroenterol, 7, 88, 10.1093/jcag/gwad020 · DOI
  100. Roohafza H, 2014, Citalopram for pediatric functional abdominal pain: a randomized, placebo‐controlled trial, Neurogastroenterol Motil, 26, 1642, 10.1111/nmo.12444 · DOI
  101. Evans S, 2014, Iyengar yoga for adolescents and young adults with irritable bowel syndrome, J Pediatr Gastroenterol Nutr, 59, 244, 10.1097/MPG.0000000000000366 · DOI
  102. Högström S, 2022, Dance and yoga reduced functional abdominal pain in young girls: a randomized controlled trial, Eur J Pain, 26, 336, 10.1002/ejp.1862 · DOI
  103. Korterink JJ, 2016, Yoga therapy for abdominal pain‐related functional gastrointestinal disorders in children: a randomized controlled trial, J Pediatr Gastroenterol Nutr, 63, 481, 10.1097/MPG.0000000000001230 · DOI
  104. Kuttner L, 2006, A randomized trial of yoga for adolescents with irritable bowel syndrome, Pain Res Manag, 11, 217, 10.1155/2006/731628 · DOI
  105. Xue H, 2019, Effect of acupuncture combined with Astragalus injection on peripheral blood inflammatory factors in children with diarrhea‐predominant irritable bowel syndrome, Eur J Inflamm, 17, 10.1177/2058739219853689 · DOI
  106. IngoC.Auswirkungen Osteopathischer Behandlung bei Kindern mit funktionellen Bauchschmerzen: Eine klinische Studie mit 32 Kindern und Jugendlichen im Alter von 6 bis 18 Jahren in Osteopathie Schule. Dissertation.Dresden International University;2019.
  107. Boradyn KM, 2020, Low FODMAP diet is not effective in children with functional abdominal pain: a randomized controlled trial, Ann Nutr Metab, 76, 334, 10.1159/000510795 · DOI
  108. Chumpitazi BP, 2015, Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome, Aliment Pharmacol Ther, 42, 418, 10.1111/apt.13286 · DOI · Paper page
  109. Chumpitazi BP, 2018, Fructans exacerbate symptoms in a subset of children with irritable bowel syndrome, Clin Gastroenterol Hepatol, 16, 219, 10.1016/j.cgh.2017.09.043 · DOI
  110. Wirth S, 2014, Positive or negative fructose breath test results do not predict response to fructose restricted diet in children with recurrent abdominal pain: results from a prospective randomized trial, Klin Padiatr, 226, 268, 10.1055/s-0034-1383653 · DOI
  111. Arrouk R, 2018, Serum‐derived bovine immunoglobulin for children with diarrhea‐predominant irritable bowel syndrome, Pediatr Health Med Ther, 9, 129, 10.2147/PHMT.S159925 · DOI
  112. Collins BS, 2011, Double‐blind, placebo‐controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain, J Pediatr Gastroenterol Nutr, 52, 382, 10.1097/MPG.0b013e3181effa3b · DOI
  113. Heyland K, 2012, No advantage for antibiotic treatment over placebo in Blastocystis hominis‐positive children with recurrent abdominal pain, J Pediatr Gastroenterol Nutr, 54, 677, 10.1097/MPG.0b013e31823a29a7 · DOI
  114. Karabulut GS, 2013, The incidence of irritable bowel syndrome in children using the Rome III criteria and the effect of trimebutine treatment, J Neurogastroenterol Motil, 19, 90, 10.5056/jnm.2013.19.1.90 · DOI
  115. Dipasquale V, 2023, Randomised controlled trial of melatonin for paediatric functional abdominal pain disorders, J Paediatr Child Health, 59, 458, 10.1111/jpc.16323 · DOI
  116. El Amrousy D, 2018, Vitamin D supplementation in adolescents with irritable bowel syndrome: is it useful? A randomized controlled trial, Saudi J Gastroenterol, 24, 109, 10.4103/sjg.SJG_438_17 · DOI
  117. Francavilla R, 2018, Randomized double‐blind placebo‐controlled crossover trial for the diagnosis of non‐celiac gluten sensitivity in children, Am J Gastroenterol, 113, 421, 10.1038/ajg.2017.483 · DOI
  118. Lävo B, 1987, Loperamide in treatment of irritable bowel syndrome—a double‐blind placebo controlled study, Scand J Gastroenterol, 22, 77, 10.3109/00365528709091003 · DOI
  119. Hovdenak N, 1987, Loperamide treatment of the irritable bowel syndrome, Scand J Gastroenterol, 22, 81, 10.3109/00365528709091004 · DOI
  120. Camilleri M, 2020, The role of bile acids in chronic diarrhea, Am J Gastroenterol, 115, 1596, 10.14309/ajg.0000000000000696 · DOI
  121. Vijayvargiya P, 2020, Effects of colesevelam on bowel symptoms, biomarkers, and colonic mucosal gene expression in patients with bile acid diarrhea in a randomized trial, Clin Gastroenterol Hepatol, 18, 2962, 10.1016/j.cgh.2020.02.027 · DOI
  122. Hoekman DR, 2017, The placebo response in pediatric abdominal pain‐related functional gastrointestinal disorders: a systematic review and meta‐analysis, J Pediatr, 182, 155, 10.1016/j.jpeds.2016.12.022 · DOI

Cited by

See all 52

Metadata

Authors
Groen, J., Gordon, M., Chogle, A., Benninga, M., Borlack, R., Borrelli, O., Darbari, A., Dolinsek, J., Khlevner, J., Di Lorenzo, C., Person, H., Sanghavi, R., Snyder, J., Thapar, N., Vlieger, A., Sinopoulou, V., Tabbers, M., & Saps, M.
Affiliations
  • Amsterdam UMC, Pediatric Gastroenterology Amsterdam The Netherlands
  • School of Medicine University of Central Lancashire Preston UK
  • Children's Hospital of Orange County Orange California USA
  • The Children's Hospital at Montefiore, Albert Einstein College of Medicine New York New York USA
  • Great Ormond Street Hospital London UK
  • Children's National Hospital, George Washington University School of Medicine and Health Sciences Washington District of Columbia USA
  • University Medical Centre Maribor Maribor Slovenia
  • Columbia University Vagelos College of Physicians and Surgeons New York New York USA
  • Nationwide Children's Hospital Columbus Ohio USA
  • Seattle Children's Hospital Seattle Washington USA
  • Children's Medical Center Dallas Texas USA
  • Boston Children's Hospital Boston Massachusetts USA
  • Queensland Children's Hospital, School of Medicine University of Queensland Brisbane Queensland Australia
  • St. Antonius Hospital Nieuwegein The Netherlands
  • University of Central Lancashire Preston UK
  • University of Miami Miami Florida USA
ORCID
Groen, Jip
Venue
Journal of Pediatric Gastroenterology and Nutrition
Publisher
Wiley
Published
2025-05-30
Volume
81
Issue
2
Pages
442-471
ISSN
  • 0277-2116
  • 1536-4801
DOI
10.1002/jpn3.70070
Cited by
52
References
22
Language
en
Licence
creativecommons.org/licenses/by-nc/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4–18 years. https://app.cochat.ai/papers/10.1002/jpn3.70070
The paper
Groen, J., Gordon, M., Chogle, A., Benninga, M., Borlack, R., Borrelli, O., Darbari, A., Dolinsek, J., Khlevner, J., Di Lorenzo, C., Person, H., Sanghavi, R., Snyder, J., Thapar, N., Vlieger, A., Sinopoulou, V., Tabbers, M., & Saps, M. (2025). ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4–18 years. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70070

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.